Table 1.
Patient demographic and clinical characteristics.
| Variable | Patient no. = 40 |
|---|---|
| Median age, years (range) | 72.5 (40–92) |
| Sex, men/women, n (%) | 31 (77.5)/9 (22.5) |
| ECOG performance status, median (range) | 1 (0–2) |
| Underlying malignancy, n (%) | |
| Pancreatobiliary cancer | 20 (50) |
| Gastric cancer | 16 (40) |
| Duodenal cancer | 3 (7.5) |
| Ascending colon cancer | 1 (2.5) |
| Surgically altered anatomy, n (%) | |
| Gastrectomy with Roux-en-Y | 19 (47.5) |
| Gastrectomy with Billroth-II | 6 (15) |
| Pancreaticoduodenectomy | 11 (27.5) |
| Hepaticojejunostomy with Roux-en-Y | 4 (10) |
| Presence of ascites, n (%) | 7 (17.5) |
| Attempt for biliary drainage prior to EUS-BD | |
| Yes/No, n (%) | 9 (22.5)/31 (77.5) |
| Laboratory values before drainage (mean ± SD) | |
| Hemoglobin (g/dl) | 10.0 ± 1.4 |
| WBC (× 102/μl) | 67.4 ± 24.8 |
| Platelet (× 104/μl) | 23.0 ± 7.7 |
| Aspartate aminotransferase (IU/L) | 130 ± 82 |
| Alanine aminotransferase (IU/L) | 115 ± 84 |
| Alkaline phosphatase (IU/L) | 1832 ± 852 |
| Total bilirubin (mg/dl) | 6.5 ± 4.2 |
| C-reactive protein (mg/dl) | 4.7 ± 3.9 |
ECOG, Eastern Cooperative Oncology Group; WBC, white blood cell.